Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Rapoport

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Southern Medical Journal|June 3, 2024
Putting a Positive Spin on the Phubbing PhenomenonStephen Landy, Christine Bahls, Alan Rapoport
The Journal of Headache and Pain|April 10, 2019
Migraine and episodic Vertigo: a cohort survey study of their relationshipChristian Lampl, Alan Rapoport, Moris Levin, et al.
Headache|May 25, 2002
Dose range-finding studies with frovatriptan in the acute treatment of migraineAlan Rapoport, Robert Ryan, Jerome Goldstein, et al.
Cephalalgia : an International Journal of Headache|April 3, 2016
Scent of aura? Clinical features of olfactory hallucinations during a migraine attack (OHM)Federico Mainardi, Alan Rapoport, Giorgio Zanchin, et al.
Headache|November 3, 2006
DHE in the pharmacotherapy of migraine: potential for a larger roleJoel R Saper, Stephen Silberstein, David Dodick, et al.
Headache|November 26, 2008
Memantine in the preventive treatment of refractory migraineMarcelo Bigal, Alan Rapoport, Fred Sheftell, et al.
Headache|July 27, 2006
Long-term migraine prevention with topiramate: open-label extension of pivotal trialsAlan Rapoport, Alexander Mauskop, Hans-Christoph Diener, et al.
Headache|April 21, 2007
Satisfaction with current migraine therapy: experience from 3 centers in US and SwedenMarcelo Bigal, Alan Rapoport, Sheena Aurora, et al.
Headache|November 26, 2008
A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraineMarcelo Bigal, Fred Sheftell, Stewart Tepper, et al.
The Journal of Headache and Pain|January 17, 2025
Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nationWanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Southern Medical Journal|June 3, 2024
Putting a Positive Spin on the Phubbing PhenomenonStephen Landy, Christine Bahls, Alan Rapoport
The Journal of Headache and Pain|April 10, 2019
Migraine and episodic Vertigo: a cohort survey study of their relationshipChristian Lampl, Alan Rapoport, Moris Levin, et al.
Headache|May 25, 2002
Dose range-finding studies with frovatriptan in the acute treatment of migraineAlan Rapoport, Robert Ryan, Jerome Goldstein, et al.
Cephalalgia : an International Journal of Headache|April 3, 2016
Scent of aura? Clinical features of olfactory hallucinations during a migraine attack (OHM)Federico Mainardi, Alan Rapoport, Giorgio Zanchin, et al.
Headache|November 3, 2006
DHE in the pharmacotherapy of migraine: potential for a larger roleJoel R Saper, Stephen Silberstein, David Dodick, et al.
Headache|November 26, 2008
Memantine in the preventive treatment of refractory migraineMarcelo Bigal, Alan Rapoport, Fred Sheftell, et al.
Headache|July 27, 2006
Long-term migraine prevention with topiramate: open-label extension of pivotal trialsAlan Rapoport, Alexander Mauskop, Hans-Christoph Diener, et al.
Headache|April 21, 2007
Satisfaction with current migraine therapy: experience from 3 centers in US and SwedenMarcelo Bigal, Alan Rapoport, Sheena Aurora, et al.
Headache|November 26, 2008
A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraineMarcelo Bigal, Fred Sheftell, Stewart Tepper, et al.
The Journal of Headache and Pain|January 17, 2025
Medication underuse in real-life practice: the impact of galcanezumab towards achieving very low frequency episodic migraine in a southeast Asian middle-income nationWanakorn Rattanawong, Prakit Anukoolwittaya, Akarin Hiransuthikul, et al.
Pageof 3